Android app Apple app link

RDY & Bio-Thera Ink Deal for JNJ's Stelara/Simponi Biosimilar

By Yahoo! Finance   |   4 weeks ago
RDY & Bio-Thera Ink Deal for JNJ's Stelara/Simponi Biosimilar

Dr. Reddy's Laboratories and Bio-Thera Solutions have signed a commercialization and license agreement for biosimilar drugs BAT2206 and BAT2506, targeting JNJ's Stelara and Simponi. This partnership will expand Dr.

Read More

Did you find this insightful?

Premium Content

This content is only available for premium members. Please become a paid member to access.

Download App

To become a member, please download and purchase membership through our app.